KRMD — Repro Med Systems Inc
NASDAQ · Healthcare · Medical Instruments & Supplies
$3.34
+$0.04 (+1.21%)
Repro Med Systems Inc (KRMD) is a medical instruments & supplies company listed on NASDAQ. It is led by Linda M. Tharby, based in 100 Corporate Drive, Mahwah, NJ, United States, 07430, with about 73 employees. KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
Latest reported KRMD revenue for 2025-09-30 was $10.4M. Net income was -$778.0K. Revenue was up 2.0% from 2025-06-30 to 2025-09-30. KRMD currently screens at market cap $186.0M.
Use this KRMD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the KRMD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the KRMD SEC filings page. Lician reads the product cache first so this HTML stays unique to Repro Med Systems Inc even when a live quote feed is slow.
About Repro Med Systems Inc
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
KRMD Key Statistics
Market Cap
$186.03M
Volume
122,862
Previous Close
$3.21
Day Range
$3.16 – $3.22
EPS
-$0.13
Revenue
$33.65M
Net Income
-$6.07M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+18.0%
Profit Margin
-18.0%
Employees
73
KRMD Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $33.65M | $28.52M | $27.90M | $23.49M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$6.07M | -$13.74M | -$8.66M | -$4.56M |
| EPS (Diluted) | -$0.13 | -$0.30 | -$0.19 | -$0.10 |
Total Assets
$27.22M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$9.58M
Operating Cash Flow
-$319.72K
Free Cash Flow
$0.00
Repro Med Systems Inc Company Information
- CEO & Director
- Linda M. Tharby
- Headquarters
- 100 Corporate Drive, Mahwah, NJ, United States, 07430
- Website
- www.korumedical.com
- Phone
- 845 469 2042
- IPO / Founded
- 1996-03-20
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies